{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:50:54Z","timestamp":1780437054780,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273261"],"award-info":[{"award-number":["82273261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ymthe.2024.12.011","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T15:02:35Z","timestamp":1734361355000},"page":"670-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors"],"prefix":"10.1016","volume":"33","author":[{"given":"Xiaozhen","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuning","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0883-1824","authenticated-orcid":false,"given":"Jiwu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.12.011_bib1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.it.2021.10.003","article-title":"Unleashing TNF cytotoxicity to enhance cancer immunotherapy","volume":"42","author":"Freeman","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/npjbcancer.2016.9","article-title":"TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients","volume":"2","author":"Comen","year":"2016","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2018.07.001","article-title":"Tumor necrosis factor-alpha promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells","volume":"434","author":"Jing","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2024.12.011_bib4","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/0008-5472.CAN-14-2524","article-title":"Blocking Tumor Necrosis Factor alpha Enhances CD8 T-cell-Dependent Immunity in Experimental Melanoma","volume":"75","author":"Bertrand","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14802","article-title":"A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer","volume":"8","author":"Betancur","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.12.011_bib7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s40425-019-0812-9","article-title":"Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer","volume":"7","author":"Zhang","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112315","article-title":"Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-\u0251 signaling","volume":"396","author":"Ju","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1162-y","article-title":"Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy","volume":"569","author":"Perez-Ruiz","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.12.011_bib10","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-017-02358-7","article-title":"TNFalpha blockade overcomes resistance to anti-PD-1 in experimental melanoma","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.12.011_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","article-title":"TNF-alpha\/NF-kappaB\/Snail pathway in cancer cell migration and invasion","volume":"102","author":"Wu","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib12","first-page":"1","article-title":"The diverse roles of the TNF axis in cancer progression and metastasis","volume":"11","author":"Ham","year":"2016","journal-title":"Trends Cancer Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.725473","article-title":"The TNF-alpha\/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response","volume":"9","author":"Moatti","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.molmed.2017.09.007","article-title":"TNFR2: A Novel Target for Cancer Immunotherapy","volume":"23","author":"Vanamee","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2024.12.011_bib15","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3389\/fimmu.2018.01170","article-title":"TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors","volume":"9","author":"Sheng","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib16","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1172\/JCI64115","article-title":"TNF signaling drives myeloid-derived suppressor cell accumulation","volume":"122","author":"Zhao","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.12.011_bib17","article-title":"MiR-125b-5p modulates the function of regulatory T\u00a0cells in tumor microenvironment by targeting TNFR2","volume":"10","author":"Jiang","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.humpath.2018.03.027","article-title":"High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma","volume":"80","author":"Liu","year":"2018","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.7150\/ijbs.72606","article-title":"TNFR2 deficiency impairs the growth of mouse colon cancer","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ymthe.2024.12.011_bib20","article-title":"Antagonistic Antibody Targeting TNFR2 Inhibits Regulatory T Cell Function to Promote Anti-Tumor Activity","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib21","article-title":"Combination cancer immunotherapy targeting TNFR2 and PD-1\/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors","volume":"10","author":"Zhang","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib22","article-title":"Blockade of TNF-alpha\/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells","volume":"16","author":"Guo","year":"2024","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.720472","article-title":"Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer","volume":"9","author":"Fu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-kappaB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","article-title":"Tumor necrosis factor blockade and the risk of viral infection","volume":"6","author":"Kim","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib27","first-page":"1885","article-title":"Tumor necrosis factor-alpha blockade and the risk of vasculitis","volume":"31","author":"Guillevin","year":"2004","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41571-022-00719-w","article-title":"Therapy with oncolytic viruses: progress and challenges","volume":"20","author":"Shalhout","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108521","article-title":"Potential targeting of the tumor microenvironment to improve cancer virotherapy","volume":"250","author":"Liao","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2024.12.011_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41392-023-01407-6","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2024.12.011_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.omto.2016.12.004","article-title":"Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy","volume":"4","author":"Havunen","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2024.12.011_bib32","article-title":"TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy","volume":"10","author":"Valenzuela-Cardenas","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-019-1917-0","article-title":"TNF-\u03b1-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer","volume":"17","author":"Zheng","year":"2019","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.ymthe.2024.12.011_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T\u00a0cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1158\/0008-5472.CAN-05-3497","article-title":"Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors","volume":"66","author":"Thomas","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib36","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000954","article-title":"Solution of the structure of the TNF-TNFR2 complex","volume":"3","author":"Mukai","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2024.12.011_bib39","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fimmu.2018.01382","article-title":"TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders","volume":"9","author":"Shaikh","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib40","first-page":"4192","article-title":"Advances in the clinical development of oncolytic viruses","volume":"14","author":"Li","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.4188","article-title":"Tumour necrosis factor and cancer","volume":"230","author":"Waters","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1158\/2159-8290.CD-22-1046","article-title":"Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer","volume":"13","author":"Bianchi","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2024.12.011_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12964-021-00775-2","article-title":"Aiduqing formula inhibits breast cancer metastasis by suppressing TAM\/CXCL1-induced Treg differentiation and infiltration","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ymthe.2024.12.011_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215598","article-title":"PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T\u00a0cells exhaustion in gastric cancer","volume":"532","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2024.12.011_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155214","article-title":"TNF-\u03b1 controls Lipocalin-2 expression in PC-3 prostate cancer cells","volume":"135","author":"Schr\u00f6der","year":"2020","journal-title":"Cytokines"},{"key":"10.1016\/j.ymthe.2024.12.011_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s43018-023-00519-w","article-title":"Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2","volume":"4","author":"Adler","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib50","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.aaz2193","article-title":"Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2024.12.011_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.903679","article-title":"Tumor Necrosis Factor alpha: Taking a Personalized Road in Cancer Therapy","volume":"13","author":"Ben-Baruch","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-023-01530-4","article-title":"Neutrophil-sourced TNF in cancer: deciphering an intricate orchestrator of immunosuppressive communication in the tumor microenvironment","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2024.12.011_bib53","article-title":"Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1","volume":"10","author":"Havunen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2024.12.011_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000188","article-title":"Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity","volume":"8","author":"Santos","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib55","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2241710","article-title":"Effective intravenous delivery of adenovirus armed with TNF\u03b1 and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer","volume":"12","author":"Kudling","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2024.12.011_bib56","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","article-title":"Inflammation: the incubator of the tumor microenvironment","volume":"8","author":"Denk","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2024.12.011_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2024.12.011_bib58","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/MPA.0b013e3182546e13","article-title":"An exploratory study of inflammatory cytokines as prognostic biomarkers in patients with ductal pancreatic adenocarcinoma","volume":"41","author":"Dima","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.ymthe.2024.12.011_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell."},{"key":"10.1016\/j.ymthe.2024.12.011_bib60","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ymthe.2024.12.011_bib61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","article-title":"IL-1\u03b2(+) macrophages fuel pathogenic inflammation in pancreatic cancer","volume":"623","author":"Caronni","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.12.011_bib62","article-title":"Targeting TNFR2 in Cancer: All Roads Lead to Rome","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaf8608","article-title":"Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs","volume":"10","author":"Torrey","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2024.12.011_bib64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/iid3.19","article-title":"Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity","volume":"2","author":"Polz","year":"2014","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.ymthe.2024.12.011_bib65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13287-020-01740-5","article-title":"TNF\u03b1\/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function","volume":"11","author":"Beldi","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2024.12.011_bib66","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.18632\/aging.204941","article-title":"TNFR2 promotes pancreatic cancer proliferation, migration, and invasion via the NF-\u03baB signaling pathway","volume":"15","author":"Gao","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ymthe.2024.12.011_bib67","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/0008-5472.CAN-20-3175","article-title":"A TNFR2-hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells","volume":"81","author":"Meng","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.12.011_bib68","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.12.011_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163802","article-title":"A paracrine circuit of IL-1\u03b2\/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression","volume":"133","author":"Chen","year":"2023","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2024.12.011_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.12.011_bib71","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41419-018-0876-3","article-title":"CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-\u03baB\/SOX4 signaling","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2024.12.011_bib72","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1038\/s41467-023-39683-z","article-title":"Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2024.12.011_bib73","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ymthe.2019.07.019","article-title":"Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1\/CD137L Subverts the Suppression of CD8(+) T Cells in HCC","volume":"27","author":"Zhang","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.12.011_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112811","article-title":"A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing","volume":"483","author":"Huang","year":"2020","journal-title":"J.\u00a0Immunol. Methods"}],"updated-by":[{"DOI":"10.1016\/j.ymthe.2025.01.033","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000}}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624008104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624008104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:54:10Z","timestamp":1770252850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624008104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1525001624008104"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.011","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}